Dosidal · Switzerland

Oxaliplatin Sandoz, Konzentrat zur Herstellung einer Infusionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:61663 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 61663
atc: L01XA03
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2011-04-15
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: L01XA03
authorisation_number: 61663
form: KOINF
holder: Sandoz Pharmaceuticals AG
holder_partner_nr: 1006431
it_number: 07.16.1.
name: Oxaliplatin Sandoz, Konzentrat zur Herstellung einer Infusionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
uOxdqS6AuEXMdLuup8KQkXs3sdGtcfD9H8VrOXjOvWo-GE6m0eFWuqNmz3DO1m4yfCbMml7L6qJu3QuB3a3maw
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal